A Randomized Controlled Trial Comparing the Management of Incomplete Abortion with Oral 600 mg Misoprostol with Manual Vacuum Aspiration (MVA)

被引:0
|
作者
Madhual, Niramaya [1 ]
Tiwari, Heena Dixit [2 ]
Das, Susmita [3 ]
Kamboj, Saloni [4 ]
Thakkar, Smit [5 ]
Kashif, Hala [6 ]
Mahajan, Akriti [7 ]
机构
[1] Padmini Care, Dept Obstet & Gynecol, Cuttack, Odisha, India
[2] Dist Med & Hlth Off, Visakhapatnam, Andhra Pradesh, India
[3] Aster DM Hosp, Dept Obstet & Gynecologist, Dubai, U Arab Emirates
[4] AIIMS, Dept Obstet & Gynaecol, Delhi, India
[5] Shri MP Shah Govt Med Coll, MBBS, Jamnagar, Gujarat, India
[6] Ayaan Inst Med Sci Teaching Hosp & Res Ctr, Hyderabad, Telangana, India
[7] MDS, Oral Med & Radiol, Jammu, Jammu & Kashmir, India
关键词
Abortion; conception; manual vacuum aspiration; misoprostol; pregnancy;
D O I
10.4103/jpbs.jpbs_496_23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In the first trimester, almost one in five identified pregnancies end in spontaneous miscarriage, and another 22% result in induced abortion. After a spontaneous and/or induced abortion, there may be retained products of conception (POC). Because of its relatively poor efficacy and the unpredictability of the time interval until spontaneous evacuation, expectant treatment is not often chosen by healthcare professionals. In view of these facts, the current study's objective was to weigh the effectiveness of MVA and oral misoprostol 600 mg in managing incomplete abortion. Materials and Procedures: The investigation was conducted at the tertiary care center in India. The survey was conducted for one year. Subjects were selected from those attending the department for either spontaneous or induced abortions. A total of 230 women were randomly assigned to receive the interventions of a single dose of oral misoprostol 600 mcg or MVA. They were equally distributed to two groups and observed for the various parameters of success, signs and symptoms, satisfaction, and complications. The obtained values were compared statistically for the significance at <0.05 of P values. Results: Of the 200 subjects (30 lost to follow-up), there was no significant variance in the demographics, clinical outcomes, and complications between the groups. However, the pain, fever, shivering, and satisfaction parameters were statistically variant between the groups. Fever, shivering, and pain were lower for the MISO subjects while satisfaction was reported higher from subjects in MISO group. Conclusion: MISO and MVA are acceptable, safe, and efficient therapies for first-trimester un-complicated incomplete abortion. Nonetheless, misoprostol appears to be a marginally superior option to MVA in terms of accessibility, low therapy costs, reduced pain, and reduced demand for specialized personnel or equipment.
引用
收藏
页码:S290 / S292
页数:3
相关论文
共 50 条
  • [41] A randomized controlled trial comparing oral sedation with intravenous sedation for first trimester surgical abortion
    Allen, R.
    Fitzmaurice, G.
    Lifford, K.
    Lasic, M.
    Goldberg, A.
    CONTRACEPTION, 2008, 78 (02) : 169 - 169
  • [42] A randomized controlled study comparing oral misoprostol with intramuscular oxytocin in active management of third stage of labour
    Sambo, Atanda Abdulrasaq
    Ijaiya, Munir'deen Aderemi
    Nwachukwu, Duum
    Nwosu, Ikemefuna Christopher
    Idris, Haruna
    Abdullateef, Rasheedat Morayo
    Adewale, Folorunsho Benard
    OBSTETRICS & GYNECOLOGY SCIENCE, 2024, 67 (03) : 279 - 285
  • [43] Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial
    Mansouri, H. A.
    Alsahly, N.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (05) : 935 - 939
  • [44] Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial
    H. A. Mansouri
    N. Alsahly
    Archives of Gynecology and Obstetrics, 2011, 283 : 935 - 939
  • [45] Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial (vol 329, pg 1197, 2023)
    Kavanagh, P. L.
    Fasipe, T.
    Wun, T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (12): : 1194 - 1194
  • [46] Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol
    Raghavan, Sheila
    Comendant, Rodica
    Digol, Irena
    Ungureanu, Sergiu
    Friptu, Valentin
    Bracken, Hillary
    Winikoff, Beverly
    CONTRACEPTION, 2009, 79 (02) : 84 - 90
  • [47] Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy
    Schaff, EA
    Fielding, SL
    Westhoff, C
    CONTRACEPTION, 2002, 66 (04) : 247 - 250
  • [48] A randomized controlled trial comparing minichest tube and needle aspiration in outpatient management of primary spontaneous pneumothorax
    Ho, Khoy Kheng
    Ong, Marcus Eng Hock
    Koh, Mariko Siyue
    Wong, Evelyn
    Raghuram, J.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (09): : 1152 - 1157
  • [49] A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor
    Ng, P. S.
    Lai, C. Y.
    Sahota, D. S.
    Yuen, P. M.
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2007, 63 (01) : 55 - 60
  • [50] A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor
    Mahajan, Niraj N.
    Mahajan, Kshitija
    Soni, Rajani
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2007, 64 (02) : 82 - 82